Global Digital Diabetes Management Market is set to grow at a healthy CAGR of 20% by 2026 - Growing Use of Data Analytics & AI in Diabetes Management

Diabetes is a chronic condition which requires constant self-management.?Digital diabetes management solutions support people with diabetes who need to adopt either lifestyle interventions or medication adjustments in response to glucose-monitoring data. Digital diabetes management solutions includes clinical programs, services, and integrated technology to support peoples' needs across the spectrum of care.

Technological Innovations in Digital Diabetes Management Market

Digital health technology, especially digital and health applications ('apps'), has been developing rapidly to help people manage their diabetes condition. For instance,

• In March 2022, Glooko Inc. acquired DIABNEXT to expand its diabetes offerings in France. DIABNEXT’s mobile app complements Glooko’s product portfolio and tracks diabetes data.
• In February 2022, Terumo Corporation entered into an agreement with Diabeloop. Under the agreement, both the companies will be integrating therapeutic artificial intelligence to automate the treatment of type 1 diabetes.

Increasing Awareness on Diabetes Self-Management Solutions Drives the Growth of Digital Diabetes Management Market

Self-management of diabetes includes diabetes education, healthy eating, physical activity, medication, device usage, monitoring, and using patient-generated data to adjust behavior and medication doses. To increase awareness, several players and governments of various countries are running awareness campaigns/training. For instance,

• Diabetes Self-Management Training (DSMT) Certification.
• Diabetes Self-Management Education and Support (DSMES) services.
• World Diabetes Day (WDD) is the world's largest diabetes awareness campaign.

Role of mHealth in Diabetes Management Boosts the Demand of Digital Diabetes Management Market

Diabetes is the most popular chronic clinical condition targeted by mHealth, followed by depression and asthma.?Mobile health (mHealth) tools have enhanced diabetes management and prevention and are likely to play an increasing role with the growth of smartphone ownership and medical device innovations. For instance,

• In May 2021, F. Hoffmann-la Roche teamed up with Ellerca Health to launch Accu-Chek + 360Care, integrating Roche’s Accu-Chek Guide blood glucose meter, customized home delivery of testing strips, and Ellerca’s self-management digital program, 360Care.

Upcoming Market Challenges: Digital Diabetes Management Market

Reimbursement issues in developing countries, high costs associated with the digital devices, rising concerns on data security, and preference for traditional diabetes management over digital diabetes management are some of the major factors which are likely to hamper the growth of the digital diabetes management market.

Geographic Overview: North America holds a Major Share in the Digital Diabetes Management Market

Currently, North America holds a major share in the global digital diabetes management market. North America is expected to continue to hold a major share in the upcoming years due to the growing prevalence of diabetes and the growing adoption of technologically advanced products, in the region.

Competitive Landscape Analysis: Digital Diabetes Management Market

Some of the established and emerging players operating in the global digital diabetes management market are 美敦力 , 雅培 , F.Hoffmann-LA Roche Ltd, Senseonics, Incorporated and Insulet Corporation , among others.

Growth Strategies Adopted by Leading Market Players to Establish Their Strong Foothold in Digital Diabetes Management Market

Players operating in the digital diabetes management market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner a higher market share. For instance,

• In April 2022, Dexcom launch Dexcom ONE Continuous Glucose Monitoring System. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) that more affordable and accessible for people with diabetes in the?UK.
• In April 2022, Abbott entered into a partnership with CamDiab and Ypsomed. Under the terms of the partnership, the three companies plan to develop and commercialize an integrated automated insulin delivery (AID) system.

Get Detailed Insights on Digital Diabetes Management Market with TOC @ https://meditechinsights.com/digital-diabetes-management-market/

#digitaldiabetesmanagement #diabetesmanagement #healthmanagement #diabetescare #diabetes #chronicdiseases #digitaldevices #medicaldevices #mhealth #mobilehealth